Neuberger Berman Group LLC Sells 14,448 Shares of Humana Inc. (NYSE:HUM)

Neuberger Berman Group LLC reduced its position in Humana Inc. (NYSE:HUM) by 4.3% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 318,693 shares of the insurance provider’s stock after selling 14,448 shares during the period. Neuberger Berman Group LLC owned 0.25% of Humana worth $140,690,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. ProShare Advisors LLC raised its stake in Humana by 19.2% in the 2nd quarter. ProShare Advisors LLC now owns 22,689 shares of the insurance provider’s stock valued at $10,045,000 after acquiring an additional 3,651 shares during the period. Canada Pension Plan Investment Board increased its position in shares of Humana by 34.6% during the first quarter. Canada Pension Plan Investment Board now owns 178,778 shares of the insurance provider’s stock valued at $74,953,000 after buying an additional 45,992 shares during the period. Public Sector Pension Investment Board increased its position in shares of Humana by 65.9% during the second quarter. Public Sector Pension Investment Board now owns 20,224 shares of the insurance provider’s stock valued at $8,954,000 after buying an additional 8,030 shares during the period. CCLA Investment Management Ltd increased its position in shares of Humana by 0.6% during the second quarter. CCLA Investment Management Ltd now owns 197,781 shares of the insurance provider’s stock valued at $87,542,000 after buying an additional 1,169 shares during the period. Finally, Weiss Multi Strategy Advisers LLC increased its position in shares of Humana by 5.3% during the first quarter. Weiss Multi Strategy Advisers LLC now owns 9,979 shares of the insurance provider’s stock valued at $4,184,000 after buying an additional 505 shares during the period. Institutional investors and hedge funds own 91.85% of the company’s stock.

In other news, Director David A. Jr/Ky Jones sold 4,800 shares of the stock in a transaction that occurred on Thursday, September 16th. The stock was sold at an average price of $401.00, for a total transaction of $1,924,800.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Corporate insiders own 0.40% of the company’s stock.

Several equities research analysts have recently weighed in on HUM shares. Zacks Investment Research upgraded Humana from a “hold” rating to a “buy” rating and set a $490.00 price target on the stock in a research report on Friday, July 16th. Cowen started coverage on Humana in a research report on Thursday, September 9th. They set an “outperform” rating and a $479.00 price target on the stock. SVB Leerink began coverage on Humana in a research report on Monday, September 27th. They set an “outperform” rating and a $494.00 price target on the stock. Morgan Stanley upped their price objective on shares of Humana from $500.00 to $513.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 31st. Finally, JPMorgan Chase & Co. upped their price objective on shares of Humana from $440.00 to $514.00 and gave the stock an “overweight” rating in a research report on Friday, July 9th. Three investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $486.92.

Shares of HUM opened at $420.69 on Thursday. The firm has a market cap of $54.06 billion, a P/E ratio of 22.24, a P/E/G ratio of 1.42 and a beta of 0.89. Humana Inc. has a 1 year low of $370.22 and a 1 year high of $475.44. The company has a debt-to-equity ratio of 0.41, a current ratio of 1.71 and a quick ratio of 1.71. The stock has a 50 day simple moving average of $406.80 and a two-hundred day simple moving average of $428.72.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 28th. The insurance provider reported $6.89 earnings per share for the quarter, beating analysts’ consensus estimates of $6.86 by $0.03. The firm had revenue of $20.65 billion during the quarter, compared to analyst estimates of $20.51 billion. Humana had a return on equity of 13.62% and a net margin of 3.09%. On average, equities analysts anticipate that Humana Inc. will post 21.49 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 29th. Stockholders of record on Thursday, September 30th will be paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 0.67%. The ex-dividend date is Wednesday, September 29th. Humana’s dividend payout ratio (DPR) is presently 14.93%.

About Humana

Humana Inc engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts.

See Also: What is the QQQ ETF?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.